Ledger.Open graph →
SEC Form D · filed March 28, 2022

Aspargo Laboratories, Inc

Offering
$60.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ENGLEWOOD CLIFFS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Michael Demurjian · Red Bank, NJExec · Director · PromoterMichael Rice · Englewood, NJDirectorPhilip M. De Bruyn · Dallas, TXDirectorGerald Birch · Huntington Beach, CAExec · Director · PromoterFred Biehl · Roseland, NJDirectorJohn T. Mitchell · Dallas, TXExec · Director · PromoterFlow State Investments GP, LLC · Chicago, ILDirectorFred Biehl · Roseland, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗